SPP1 and cancer: Nevertheless, the implication of OPN in existing standard-of-care treatments for patients with cancer has been reviewed, in which cancer cell intrinsic and paracrine OPN signaling consistently supports chemotherapy, radiotherapy, and immunotherapy resistance in various cancers (9, 166).